Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

MOLOGEN AG

MOLOGEN is specializing in selected areas of Molecular Medicine. Our areas of competence are gene expression, gene therapy and bioinformatics. We are dedicated to the development of DNA expression and delivery technologies for human and veterinary applications, leading to products for gene therapy, and prophylactic and therapeutic DNA-based vaccines


Contact Details:
Fabeckstr. 30
Berlin
14195
Germany
Tel:49-30-84 17 88 - 0
Fax:49-30-84 17 88 - 50
Email:info@mologen.com
WWW:

www.mologen.com/




Recent Publications by MOLOGEN AG:

Cytokine and Ig-production by CG-containing sequences with phosphorodiester backbone and dumbbell-shape.
BACKGROUND: Immunostimulatory oligodeoxynucleotides (CpG-ODN) usually...
8th June, 2006
Mologen AG, Berlin, Germany. Allergy. 2006 Jan;61(1):56-63.
DOI Direct Link

BioNews Results for MOLOGEN AG:

Mologen gets US patent for cell-based gene therapy to treat cancer
PharmaBiz:  Aug 28 2009 5:27AM Matching: mologen ag

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 275 times since April 2007, the link to the organisation's website has been followed 59 times

Search for more companies in Berlin

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for MOLOGEN AG

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.